STAT
STAT+: AbbVie wins FDA nod for Parkinson’s pill
The FDA has approved AbbVie’s once-daily Parkinson’s pill for sales, based on a late-stage study that showed the drug helped improve symptoms.
Meghana Keshavan
Rights: fair use excerpt

---
Meghana Keshavan · STAT News · Photo: Adobe
Source & Credit
Reporting and photography credited as noted above. Originally published by STAT News.
Members only
Checking your membership…